498 related articles for article (PubMed ID: 9383684)
1. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity.
van't Hof RJ; Ralston SH
J Bone Miner Res; 1997 Nov; 12(11):1797-804. PubMed ID: 9383684
[TBL] [Abstract][Full Text] [Related]
2. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide: a cytokine-induced regulator of bone resorption.
Ralston SH; Ho LP; Helfrich MH; Grabowski PS; Johnston PW; Benjamin N
J Bone Miner Res; 1995 Jul; 10(7):1040-9. PubMed ID: 7484279
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and bone.
Evans DM; Ralston SH
J Bone Miner Res; 1996 Mar; 11(3):300-5. PubMed ID: 8852940
[TBL] [Abstract][Full Text] [Related]
5. Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha.
Lee SK; Huang H; Lee SW; Kim KH; Kim KK; Kim HM; Lee ZH; Kim HH
Exp Cell Res; 2004 Aug; 298(2):359-68. PubMed ID: 15265685
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts.
Lin SK; Kok SH; Kuo MY; Lee MS; Wang CC; Lan WH; Hsiao M; Goldring SR; Hong CY
J Bone Miner Res; 2003 Jan; 18(1):39-46. PubMed ID: 12510804
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.
Maciejewski JP; Selleri C; Sato T; Cho HJ; Keefer LK; Nathan CF; Young NS
J Clin Invest; 1995 Aug; 96(2):1085-92. PubMed ID: 7543491
[TBL] [Abstract][Full Text] [Related]
8. Combinatory responses of proinflamamtory cytokines on nitric oxide-mediated function in mouse calvarial osteoblasts.
Park YG; Kim KW; Song KH; Lee JM; Hong JJ; Moon SK; Kim CH
Cell Biol Int; 2009 Jan; 33(1):92-9. PubMed ID: 18957328
[TBL] [Abstract][Full Text] [Related]
9. IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.
Kohara H; Kitaura H; Fujimura Y; Yoshimatsu M; Morita Y; Eguchi T; Masuyama R; Yoshida N
Immunol Lett; 2011 Jun; 137(1-2):53-61. PubMed ID: 21338623
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone resorption and osteoclast survival by nitric oxide: possible involvement of NMDA-receptor.
Mentaverri R; Kamel S; Wattel A; Prouillet C; Sevenet N; Petit JP; Tordjmann T; Brazier M
J Cell Biochem; 2003 Apr; 88(6):1145-56. PubMed ID: 12647297
[TBL] [Abstract][Full Text] [Related]
11. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
12. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
16. The flurbiprofen derivatives HCT1026 and HCT1027 inhibit bone resorption by a mechanism independent of COX inhibition and nitric oxide production.
Idris AI; Del Soldato P; Ralston SH; van't Hof RJ
Bone; 2004 Sep; 35(3):636-43. PubMed ID: 15336599
[TBL] [Abstract][Full Text] [Related]
17. IL-12- and IL-18-mediated, nitric oxide-induced apoptosis in TNF-α-mediated osteoclastogenesis of bone marrow cells.
Kitaura H; Fujimura Y; Yoshimatsu M; Kohara H; Morita Y; Aonuma T; Fukumoto E; Masuyama R; Yoshida N; Takano-Yamamoto T
Calcif Tissue Int; 2011 Jul; 89(1):65-73. PubMed ID: 21611811
[TBL] [Abstract][Full Text] [Related]
18. Osteocytes subjected to fluid flow inhibit osteoclast formation and bone resorption.
Tan SD; de Vries TJ; Kuijpers-Jagtman AM; Semeins CM; Everts V; Klein-Nulend J
Bone; 2007 Nov; 41(5):745-51. PubMed ID: 17855178
[TBL] [Abstract][Full Text] [Related]
19. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts.
Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T
J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830
[TBL] [Abstract][Full Text] [Related]
20. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN.
Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH
J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
